BioNTech SE (VIE:BNTX)
Austria · Delayed Price · Currency is EUR 77.75
-0.05 (-0.06%)
At close: Apr 2, 2026
BioNTech SE Revenue
In the year 2025, BioNTech SE had annual revenue of 2.87B EUR with 4.32% growth. BioNTech SE had revenue of 907.40M in the quarter ending December 31, 2025, a decrease of -23.75%.
Revenue
2.87B
Revenue Growth
+4.32%
P/S Ratio
6.97
Revenue / Employee
367.61K
Employees
7,807
Market Cap
20.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.87B | 118.80M | 4.32% |
| Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
| Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 23.62B |
| Strabag SE | 17.92B |
| Voestalpine AG | 15.14B |
| Vienna Insurance Group AG | 13.64B |
| Erste Group Bank AG | 11.21B |
| Raiffeisen Bank International AG | 8.98B |
| VERBUND AG | 8.03B |
| Andritz AG | 7.90B |